Evidence map›Paper›PMID 29112802›Full record

GuidelineArthritis care & research2018

Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions.

Yongdong Zhao, Eveline Y Wu, Melissa S Oliver, Ashley M Cooper, Matthew L Basiaga, Sheetal S Vora, Tzielan C Lee, Emily Fox, Gil Amarilyo, Sara M Stern and 21 more

Registry-linked trialOpen access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Arthritis care & research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04725422 (CHronic Nonbacterial Osteomyelitis International Registry), which is not on this map. Cited by 96 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 4 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04725422 recruitingnot on this map

CHronic Nonbacterial Osteomyelitis International Registry (CHOIR)

TypeobservationalSponsorSeattle Children's HospitalRan2018 to 2050Enrolled2,000ConditionsChronic Nonbacterial Osteomyelitis, Chronic Recurrent Multifocal OsteomyelitisArmsMethotrexate, Sulfasalazine, Leflunomide, Pamidronate, Zoledronic acid
3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 4 syntheses or guidelines pooled it, 224 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. HLA-B*27 is associated with CNO in a European cohort.Pediatric rheumatology online journal · 2023
    Pooled it
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Chronic Recurrent Multifocal Osteomyelitis: A Review of 80 Cases in Chinese Children.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 6 countries.

Yongdong ZhaoSeattle Children's Hospital, University of Washington, Seattle.ORCID 0000-0003-3618-1379
Eveline Y WuUniversity of North Carolina, Chapel Hill.
Melissa S OliverStanford Children's Health, Stanford University, Palo Alto, California.
Ashley M CooperChildren's Mercy, Kansas City, Missouri.
Matthew L BasiagaSeattle Children's Hospital, University of Washington, Seattle.ORCID 0000-0003-2869-1037
Sheetal S VoraLevine Children's Hospital, Charlotte, North Carolina.
Tzielan C LeeStanford Children's Health, Stanford University, Palo Alto, California.
Emily FoxChildren's Mercy, Kansas City, Missouri.
Gil AmarilyoSchneider Children's Medical Center of Israel, Petach Tikva Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sara M SternUniversity of Utah, Salt Lake City.
Jeffrey A DvergstenDuke Children's Hospital, Durham, North Carolina.
Kathleen A HainesJoseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey.
Kelly A Rouster-StevensChildren's Healthcare of Atlanta, Emory University, Atlanta, Georgia.
Karen B OnelHospital for Special Surgery, New York, New York.
Julie CherianStony Brook Children's Hospital, Stony Brook, New York.
Jonathan S HausmannBoston Children's Hospital and Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Paivi MiettunenUniversity of Calgary, Calgary, Alberta, Canada.
Tania CellucciMcMaster Children's Hospital, Hamilton, Ontario, Canada.
Farzana NuruzzamanStony Brook Children's Hospital, Stony Brook, New York.
Angela TanejaChildren's Healthcare of Atlanta, Emory University, Atlanta, Georgia.
Karyl S BarronNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Matthew C HollanderUniversity of Vermont Medical Center, Burlington.
Sivia K LapidusGoryeb Children's Hospital, Morristown, New Jersey.
Suzanne C LiJoseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey.ORCID 0000-0001-8276-2866
Seza OzenHacettepe University, Ankara, Turkey.
Hermann GirschickVivantes Children's Hospital in Friedrichshain, Berlin, Germany.
Ronald M LaxerThe Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
Fatma DedeogluBoston Children's Hospital, Boston, Massachusetts.
Christian M HedrichChildren's Hospital Dresden, University Medical Center Carl Gustav Carus, TU Dresden, Dresden, Germany, and Institute of Translational Medicine, University of Liverpool, and Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK.
Polly J FergusonUniversity of Iowa Carver College of Medicine, Iowa City.
Chronic Nonbacterial Osteomyelitis/Chronic Recurrent Multifocal Osteomyelitis Study Group and the Childhood Arthritis and Rheumatology Research Alliance Scleroderma, Vasculitis, Autoinflammatory and Rare Diseases Subcommittee
Boston Children's Hospital · USChildren's Mercy Hospital · USEmory University · USHackensack University Medical Center · USSeattle Children's Hospital · USStanford University · USStony Brook Children's Hospital · USDuke Children's Hospital & Health Center · USGoryeb Children's Hospital · USHacettepe University · TRHospital for Special Surgery · USKlinikum im Friedrichshain · DELevine Children's Hospital · USMcMaster Children's Hospital · CANational Institutes of Health · USTel Aviv University · ILUniversity of Calgary · CAUniversity of Iowa · USUniversity of Liverpool · GBUniversity of North Carolina at Chapel Hill · US

Funding

Clinical Pharmacoepidemiology Training ProgramT32GM075766 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Sean Hennessy, Charles Edward Leonard · 2006 to 2026
$8.4M
Training Program in Adult and Pediatric RheumatologyT32AR050942 · NIAMS · STANFORD UNIVERSITY · PI LEWIS, DAVID BRAM, ROBINSON, WILLIAM H · 2005 to 2025
$6.6M
Genetic & immunologic etiology of chronic recurrent multifocal osteomyelitis-CRMOR01AR059703 · NIAMS · UNIVERSITY OF IOWA · PI BASSUK, ALEXANDER G, FERGUSON, POLLY J · 2010 to 2019
$3.5M
NIAMS NIH HHS R01 AR059703NIAMS NIH HHS T32 AR050942NIGMS NIH HHS T32 GM075766
6 · The paper itself

Abstract

objectiveTo develop standardized treatment regimens for chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO), to enable comparative effectiveness treatment studies.

methodsVirtual and face-to-face discussions and meetings were held within the CNO/CRMO subgroup of the Childhood Arthritis and Rheumatology Research Alliance (CARRA). A literature search was conducted, and CARRA membership was surveyed to evaluate available treatment data and identify current treatment practices. Nominal group technique was used to achieve consensus on treatment plans for CNO refractory to nonsteroidal antiinflammatory drug (NSAID) monotherapy and/or with active spinal lesions.

resultsThree consensus treatment plans (CTPs) were developed for the first 12 months of therapy for CNO patients refractory to NSAID monotherapy and/or with active spinal lesions. The 3 CTPs are methotrexate or sulfasalazine, tumor necrosis factor inhibitors with optional methotrexate, and bisphosphonates. Short courses of glucocorticoids and continuation of NSAIDs are permitted for all regimens. Consensus was achieved on these CTPs among CARRA members. Consensus was also reached on subject eligibility criteria, initial evaluations that should be conducted prior to the initiation of CTPs, and data items to collect to assess treatment response.

conclusionThree consensus treatment plans were developed for pediatric patients with CNO refractory to NSAIDs and/or with active spinal lesions. Use of these CTPs will provide additional information on efficacy and will generate meaningful data for comparative effectiveness research in CNO.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalAntirheumatic AgentsBiological ProductsOsteomyelitisPatient Care PlanningSpinal DiseasesAdolescentChildConsensusFemaleHumansMalePrognosisRetreatmentRisk AssessmentSeverity of Illness IndexAnti-Inflammatory Agents, Non-SteroidalAntirheumatic AgentsBiological Products

Identifiers

PMID29112802
PMCPMC5938153
OpenAlexW2767736224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.